Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details)

v3.19.3
Note 5 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Jun. 30, 2019
Total assets $ 58,520 $ 65,147
Contingent consideration 13,300 12,600
Derivative instruments - cash flow hedges 13,116 12,458
Total liabilities 26,416 25,058
Fair Value, Inputs, Level 1 [Member]    
Total assets 58,520 65,147
Contingent consideration 0 0
Derivative instruments - cash flow hedges 0 0
Total liabilities 0 0
Fair Value, Inputs, Level 2 [Member]    
Total assets 0 0
Contingent consideration 0 0
Derivative instruments - cash flow hedges 13,116 12,458
Total liabilities 13,116 12,458
Fair Value, Inputs, Level 3 [Member]    
Total assets 0 0
Contingent consideration 13,300 12,600
Derivative instruments - cash flow hedges 0 0
Total liabilities 13,300 12,600
Equity Securities [Member]    
Investments, Fair Value Disclosure [1] 27,819 38,219
Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]    
Investments, Fair Value Disclosure [1] 27,819 38,219
Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]    
Investments, Fair Value Disclosure [1] 0 0
Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]    
Investments, Fair Value Disclosure [1] 0 0
Certificates of Deposit [Member]    
Investments, Fair Value Disclosure [2] 30,701 26,928
Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]    
Investments, Fair Value Disclosure [2] 30,701 26,928
Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]    
Investments, Fair Value Disclosure [2] 0 0
Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]    
Investments, Fair Value Disclosure [2] $ 0 $ 0
[1] Included in available-for-sale investments on the balance sheet. The cost basis in the Company's investment in ChemoCentryx Inc (CCXI) at September 30, 2019 and June 30, 2019 was $18.8 million
[2] Included in available-for-sale investments on the balance sheet. The certificate of deposits have contractual maturity dates within one year.